BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26391478)

  • 1. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
    Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
    Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
    Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High numbers of human skin cancers express MMP2 and several integrin genes.
    Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
    J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
    Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
    Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies.
    Zolfaghari MA; Karimi A; Kalantari E; Korourian A; Ghanadan A; Kamyab K; Esmaili N; Emami Razavi AN; Madjd Z
    BMC Cancer; 2020 Jun; 20(1):567. PubMed ID: 32552892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
    Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
    Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model.
    Geißler C; Hambek M; Leinung M; Diensthuber M; Gassner D; Stöver T; Wagenblast J
    In Vivo; 2012; 26(4):593-8. PubMed ID: 22773573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Merino JM; Morales-Hernández A; Rodríguez MI; Rey-Barroso J; Barrasa E; Cerezo-Guisado MI; Catalina-Fernández I; Sáenz-Santamaría J; Oliver FJ; Fernandez-Salguero PM
    Mol Cancer; 2015 Aug; 14():148. PubMed ID: 26242870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
    Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
    Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
    Oon ML; Thike AA; Tan SY; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):31-41. PubMed ID: 25677743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
    Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
    Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma.
    Nguyen PH; Giraud J; Chambonnier L; Dubus P; Wittkop L; Belleannée G; Collet D; Soubeyran I; Evrard S; Rousseau B; Senant-Dugot N; Mégraud F; Mazurier F; Varon C
    Clin Cancer Res; 2017 Mar; 23(6):1586-1597. PubMed ID: 27620279
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO3 is essential for CD44 expression in pancreatic cancer cells.
    Kumazoe M; Takai M; Bae J; Hiroi S; Huang Y; Takamatsu K; Won Y; Yamashita M; Hidaka S; Yamashita S; Yamada S; Murata M; Tsukamoto S; Tachibana H
    Oncogene; 2017 May; 36(19):2643-2654. PubMed ID: 27893718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
    Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
    Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.